Target product profile (TPP) for chagas disease point-of-care diagnosis and assessment of response to treatment
Authors
Porrás, Analía IYadon, Zaida E
Altcheh, Jaime
Britto, Constança
Chaves, Gabriela C
Flevaud, Laurence
Martins-Filho, Olindo Assis
Ribeiro, Isabela
Schijman, Alejandro G
Shikanai-Yasuda, Maria Aparecida
Sosa-Estani, Sergio
Stobbaerts, Eric
Zicker, Fabio
Issue Date
2015-06-04
Metadata
Show full item recordJournal
PLoS Neglected Tropical DiseasesPublisher
Public Library of SciencePubMed ID
26042730Language
enISSN
1935-2735ae974a485f413a2113503eed53cd6c53
10.1371/journal.pntd.0003697
Scopus Count
Collections
Related articles
- Optimising diagnosis of viraemic hepatitis C infection: the development of a target product profile.
- Authors: Ivanova Reipold E, Easterbrook P, Trianni A, Panneer N, Krakower D, Ongarello S, Roberts T, Miller V, Denkinger C
- Issue date: 2017 Nov 1
- Matching diagnostics development to clinical need: Target product profile development for a point of care test for community-acquired lower respiratory tract infection.
- Authors: Gal M, Francis NA, Hood K, Villacian J, Goossens H, Watkins A, Butler CC, RAPP-ID consortium.
- Issue date: 2018
- Considerations in developing a target product profile for parenteral pharmaceutical products.
- Authors: Lambert WJ
- Issue date: 2010 Sep
- AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL.
- Authors: Sondhi D, Peterson DA, Giannaris EL, Sanders CT, Mendez BS, De B, Rostkowski AB, Blanchard B, Bjugstad K, Sladek JR Jr, Redmond DE Jr, Leopold PL, Kaminsky SM, Hackett NR, Crystal RG
- Issue date: 2005 Nov
- Novel Gallate Triphenylphosphonium Derivatives with Potent Antichagasic Activity.
- Authors: Cortes LA, Castro L, Pesce B, Maya JD, Ferreira J, Castro-Castillo V, Parra E, Jara JA, López-Muñoz R
- Issue date: 2015